1.George JR, Fitchen JH. Future applications of oral fluid specimen technology. American Journal of Medicine 1997; 102: 21–25.
2.Nokes DJ, et al. Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. Bulletin of the World Health Organisation 2001; 79: 588–595.
3.McKie A, Vyse A, Maple C. Novel methods for the detection of microbial antibodies in oral fluid. Lancet Infectious Diseases 2002; 2: 18–24.
4.Morris MC, et al. Oral fluid collection by post – a pilot study of two approaches. Public Health 2002; 116: 113–119.
5.Morris MC, et al. Stability of total and rubella-specific IgG in oral fluid samples: the effect of time and temperature. Journal of Immunological Methods 2002; 266: 111–116.
6.von Mutius E. Allergies, infections and the hygiene hypothesis – the epidemiological evidence. Immunobiology 2007; 212: 433–439.
7.Smith K, Joshi H. The Millennium Cohort Study. Population Trends 2002; 107: 30–34.
12.Hansen K. Millennium Cohort Study First and Second Surveys: A Guide to the Datasets, 1st edn.London: Institute of Education, University of London, 2006.
14.Vyse AJ, Cohen BJ, Ramsay ME. A comparison of oral fluid collection devices for use in the surveillance of virus diseases in children. Public Health 2001; 115: 201–207.
15.Nokes DJ, et al. An evaluation of oral-fluid collection devices for the determination of rubella antibody status in a rural Ethiopian community. Transactions of the Royal Society of Tropical Medicine and Hygiene 1998; 92: 679–685.
16.Rose D, Pevalin DA. A Researchers Guide to the National Statistics Socioeconomic Classification. London: Sage Publications, 2003.
18.Zou G. A modified Poisson regression approach to prospective studies with binary data. American Journal of Epidemiology 2004; 159: 702–706.
19.Petersen MR, Deddens JA. A comparison of two methods for estimating prevalence ratios. BMC Medical Research Methodology 2008; 8: 9.
20.Stata Corporation. Survey Data Reference Manual Release 9. Stata Press, 2005.
21.Ochnio JJ, et al. Participant-collected, mail-delivered oral fluid specimens can replace traditional serosurveys: a demonstration-of-feasibility survey of hepatitis A virus-specific antibodies in adults. Canadian Journal of Public Health 2007; 98: 37–40.
22.Morris-Cunnington MC, et al. A population-based seroprevalence study of Hepatitis A virus using oral fluid in England and Wales. American Journal of Epidemiology 2004; 159: 786–794.
23.O'Connell T, et al. Oral fluid collection by post for viral antibody testing. International Journal of Epidemiology 2001; 30: 298–301.
24.Chatzipantazi P, et al. The feasibility and acceptability of collecting oral fluid from healthy children for anti-HCV testing. Archives of Disease in Childhood 2004; 89: 185–187.
25.Crowcroft NS, et al. Epidemiology of Epstein-Barr virus infection in pre-adolescent children: application of a new salivary method in Edinburgh, Scotland. Journal of Epidemiology and Community Health 1998; 52: 101–104.
26.Gibbs S, et al. Atopic dermatitis and the hygiene hypothesis. International Journal of Epidemiology 2004; 33: 199–207.
27.Rothmier JD, Lasley MV, Shapiro G. Factors influencing parental consent in pediatric clinical research. Pediatrics 2003; 111; 1037–1041.
28.Tait A, Voepel-Lewis T, Malviya S. Participation of children in clinical research: factors that influence a parent's decision to consent. Anesthesiology 2003; 99: 819–825.
29.Sabri AA, Qayyum MA. Increasing the participation: another factor. PLoS Med 2005; 3: e250.
30.Hunt SM, Bhopal R. Self report in clinical and epidemiological studies with non-English speakers, the challenge of language and culture. Journal of Epidemiology and Community Health 2004; 58: 618–622.
31.Hunt S, Bhopal R. Self reports in research with non-English speakers. British Medical Journal 2003; 327: 352–353.
32.Bartlett C, et al. The causes and effects of socio-demographic exclusions from clinical trials. Health Technology Assessment 2005; 9: 1–152.
33.Hussain-Gambles M, Atkin K, Leese B. Why ethnic minority groups are under-represented in clinical trials: a review of the literature. Health and Social Care in the Community 2004; 12: 382–388.
34.Hussain-Gambles M, et al. Involving South Asian patients in clinical trials. Health Technology Assessment 2004; 42: 1–109.
35.Mason S, et al. Representation of South Asian people in randomised clinical trials: analysis of trials' data. British Medical Journal 2003; 326: 1244–1245.
36.Chan H, Moriarty K. Are ethnic minorities excluded from clinical research? Bulletin of Medical Ethics. 2005; 211: 22–24.
37.Lamvu G, et al. Racial differences among reasons for participating in research of pregnancy outcomes: The right from the start experience Gender Medicine 2005; 2: 166–173.
38.Crider KS, et al. Racial and ethnic disparity in participation in DNA collection at the Atlanta Site of the National Birth Defects Prevention Study. American Journal of Epidemiology 2006; 164: 805–812.
39.Shavers VL, et al. Racial differences in factors that influence the willingness to participate in medical research studies. Annals of Epidemiology 2002; 12: 248–256.
40.Sheikh A. Why are ethnic minorities under-represented in US research studies? PLoS Med 2005; 3: e49.